Expert Discusses Pulmonary Nodules and Lung Cancer Screening

OSUWexnerbloglogo2014 Expert Discusses Pulmonary Nodules and Lung Cancer Screening. Today on MedNet21, we are going to help you use the chest CT in your own clinical practice in order to save lives. My guest is pulmonologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Mike Wert.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: develop an evidence-based approach to the management of solitary pulmonary nodules; and understand the evidence behind and the importance of lung cancer screening in high-risk patients.

You’ll also learn about the following:

  • Efficacy of lung cancer screening
  • Challenges with lung cancer screening?

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Online Webast Series Teaches On Health Screening for Non-Malignant Diseases

OSUWexnerbloglogo2014 Online Webast Teaches On Health Screening for Non-Malignant Diseases. On this CME webcast, we are going to be discussing current recommendations for health screening with a focus on screening for non-cancer conditions. First, to tell us about screening in children is Assistant Professor of Family Medicine, Dr. Rachel McGuirk. And then to update us about health screening in adults is Assistant Professor of Family Medicine, Dr. Sondos Al Sad.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: discuss the role of the USPSTF and how to interpret their recommendations; review pediatric preventative measures including physical examination, screening questionnaires, laboratory testing, and behavioral interventions; recognize top health screenings that impact morbidity and mortality of general population; and prioritize preventive health screenings based on informed discussion with patients.

You’ll also learn about the following:

  • What age screening should start
  • Where screening guidelines come from
  • The childhood growth chart
  • Which lipid tests you should order
  • Dementia screening
  • Tests used for syphilis and other sexually-transmitted diseases

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Webcast Teaches on Prostate Cancer Screening

OSUWexnerbloglogo2014 On-line CME Webcast Teaches on Prostate Cancer Screening. On this CME webcast, we’ll be examining the conundrum of prostate cancer screening. Joining our moderator in the studio is urologic oncologist and Assistant Professor of Urology, Dr. Shawn Dason.

 

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the rationale, benefits, and harms of prostate cancer screening; and DEVELOP an approach for prostate cancer screening in a primary care setting.

You’ll also learn about the following:

  • Prostate cancer risk factors
  • The problem with the PSA
  • False positive PSAs
  • False negative PSAs
  • Interpreting the PSA trajectory over time
  • The urologist’s approach to an elevated PSA
  • Common prostate cancer treatments and their complications

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Pancreatic Cancer

OSUWexnerbloglogo2014 CME Webcast Teaches on Pancreatic Cancer. One out of 64 people in the United States will die of pancreatic cancer; it is the 4th leading cause of cancer death. On this CME webcast, we are going to take a look at pancreatic cancer: its causes, its diagnosis, and its treatment. We’re pleased to welcome today’s guest. Dr. Mary Dillhoff is a surgical oncologist and Assistant Professor of Surgery here at the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY and learn the types of premalignant pancreas cyst and when surgical referral or further work up is indicated; and DESCRIBE work up and staging or pancreatic cancer and the treatment options.

You’ll also learn about the following:

  • Pancreatic cancer survival
  • Screening for pancreatic cancer
  • Medical management issues after a Whipple procedure
  • Post-op cancer follow up

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Macular Degeneration

OSUWexnerbloglogo2014 CME Webcast Discusses Macular Degeneration. On this CME webcast, we’re going to update you on the current approaches to the diagnosis and treatment of macular degeneration. Let me welcome today’s guests. Dr. Matthew Ohr is an Associate Professor of Ophthalmology and the Interim Chairman of the Department of Ophthalmology. And Dr. Fatoumata Yanoga is a retinal specialist and Assistant Professor of Ophthalmology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW Characteristics of Age-Related Macular Degeneration; DISCUSS Modifiable Risk Factors that can Lead to Prevention of Disease; DEFINE neovascular macular degeneration; and DISCUSS the diagnosis and management of wet macular degeneration.

You’ll also learn about the following:

  • Risk factors for macular degeneration
  • Prognosis of macular degeneration
  • Screening for macular degeneration in the primary care office
  • Assessing risks when starting a patient on anticoagulation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.